|
Title
|
Published
|
Price
|
|
The UAV Market Report: Forecasts and analysis 2008-2018
By: Visiongain
The UAV market has grown rapidly in the last decade providing considerable value strategically and tactically. The global appetite for UAVs shows no sign of abating. Instead, there is a growing indication that countries are
|
more...
|
6/12/2008
|
$2,600.00
|
|
Mobile Adult Content 2008 - Securing Revenue from Adult Entertainment
By: Visiongain
Adult content is a huge business and is one of the few entertainment industries to have withstood economic pressures which have led to sectors such as the music industry, witnessing a decline. On the internet,
|
more...
|
6/8/2008
|
$3,000.00
|
|
Silverlight Mobile 2008: Developing the Platform for the Future of Mobile Content
By: Visiongain
When Microsoft ™ creates a new product that it intends to roll out across its future operating systems to enable an enhanced multimedia experience from the internet, then web developers and the internet community need
|
more...
|
5/16/2008
|
$3,000.00
|
|
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
By: Visiongain
The pharmaceutical industry is one of the fastest growing sectors in Indian economy. Visiongain predicts that market for pharmaceuticals in India has strong potential for increased growth from 2008 right through to 2023. The industry’s
|
more...
|
5/16/2008
|
$3,000.00
|
|
Lipitor Market analysis and forecasts Report, 2007-2012, 2017 & 2023
By: Visiongain
In 2006, Pfizer’s Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history. The blockbuster medicine has single-handedly driven the overall revenue margins of the cardiovascular segment, as this
|
more...
|
4/30/2008
|
$3,000.00
|
|
Mobile Remittance - A Window for the Financial Empowerment of Global Communities through Mobility
By: Visiongain
While the use of high-tech electronic substitutes for cash was always expected to infiltrate developed markets such as Japan, mobile wallets and electronic transfers were perceived as requiring much time to reach poorer countries. Case
|
more...
|
4/16/2008
|
$3,000.00
|
|
Chinese Pharmaceutical Outlook 2008-2023
By: Visiongain
This brand new report examines the prospects for the growth of pharmaceutical revenues in China. Visiongain predicts that total pharmaceutical revenues in China will increase from approximately $12bn in 2007 to over $30bn in 2013.
|
more...
|
4/16/2008
|
$3,000.00
|
|
Blood Disorders Market Analysis & Forecasts Report to 2013
By: Visiongain
In 2007, blood diseases cost the US’s economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively.
|
more...
|
4/14/2008
|
$3,000.00
|
|
Mobile search 2008-2013: Profiting From Information and Advertising on the Move
By: Visiongain
Search has transported from the internet to the mobile and has been identified as an area of enormous growth. Mobile subscribers are currently tentative. But with growing confidence they are exploring the internet over their
|
more...
|
3/28/2008
|
$3,000.00
|
|
Sleep Disorders Market Analysis 2008-2018
By: Visiongain
More than 80 sleep disorders have been identified. They affect over 200 million people worldwide. The report focuses on the market for following sleep disorders:
|
more...
|
3/25/2008
|
$3,000.00
|
|
The Antibacterial Drug Market Analysis 2008-2013
By: Visiongain
This brand new market analysis by visiongain examines the prospects for antibacterial drugs from 2008-2013, including sales forecasts for leading pharmaceutical products. The antibacterial market is large in terms of disease area as well as
|
more...
|
3/19/2008
|
$3,000.00
|
|
Google in Mobile 2008
By: Visiongain
Google is the world’s most popular internet search engine. However with more people in the world having access to a mobile phone than a computer, Google is turning its attentions to the mobile market. Many
|
more...
|
2/28/2008
|
$3,000.00
|
|
Generic League - Market Analysis and Forecasts, 2007-2012, 2017 & 2022
By: Visiongain
The generic industry is a fast evolving market; with significant lucrative opportunities. The generic market is structurally set to experience high growth potential. That wave is partly driven by cost-containment in several national healthcare sectors
|
more...
|
2/27/2008
|
$4,000.00
|
|
Google’s Android and Mobile Linux Report 2008 - A Google-led Initiative to Reshape the Mobile Market Environment
By: Visiongain
Google have launched the Android mobile operating system. The announcement was welcomed across large sections of the mobile industry, however the future prospects for this new Linux-based platform and for the shape of the mobile
|
more...
|
2/23/2008
|
$3,100.00
|
|
Fixed-Mobile Convergence Market Analysis 2008
By: Visiongain
The GSM Association is to test out a carrier ENUM service, which the trade body says will make it easier to send IMs, MMS, emails, videos and any other IP content between mobiles and fixed
|
more...
|
2/21/2008
|
$3,000.00
|
|
The Antipsychotics Market Insight & Analysis 2008
By: Visiongain
The total antipsychotics market revenue in 2006 was $18.1bn. Visiongain predicts that total revenues in the antipsychotics market will peak to $18.6bn by 2007. But what will it be in 2012? This report will tell
|
more...
|
2/19/2008
|
$3,000.00
|
|
Mobile Social Networking and User Generated Content Market Insight 2008
By: Visiongain
Vodafone have just announced a tie-up with Facebook for mobile phone activity.
Facebook has launched a platform for operators designed to make its social networking application work better on portable devices. Vodafone is the first
|
more...
|
2/12/2008
|
$3,000.00
|
|
Respiratory Market Insight 2008
By: Visiongain
This brand new report examines the forthcoming prospects for respiratory drugs over the next 5 year. With in-depth sales forecasts for leading pharmaceutical products, the report has been produced to inform you of future developments
|
more...
|
2/11/2008
|
$3,000.00
|
|
Erectile Dysfunction Market Assessment & Analysis 2007-2022
By: Visiongain
The market for Erectile Dysfunction (ED) drugs is growing fast with a CAGR of 4.9% for the period 2006-2012. The ED market contains three leading drugs Viagra, Levitra and Cialis. Viagra, already a blockbuster drug,
|
more...
|
2/1/2008
|
$3,100.00
|
|
Live-Licensing & In-life testing: R&D Processes and Regulation for New Drugs, 2008-2020
By: Visiongain
Visiongain predict that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as “in-life” testing or “live” licensing. Those proposals involve cumulative testing of
|
more...
|
1/17/2008
|
$3,000.00
|
|
Parkinson's Disease Market Analysis and Forecasts, 2008-2012, 2017 & 2022
By: Visiongain
Parkinson's disease (PD) is the second most common neurological disorder, affecting approximately 4.1m people worldwide. As the prevalence rate of PD is set to rise significantly in the coming years, clinical interventions will play a
|
more...
|
1/8/2008
|
$3,100.00
|
|
UMTS 900 - Successfully Delivering 3G in Low-Frequency Bands
By: Visiongain
UMTS is now a firmly established technology. It is gaining mass market adoption, with DoCoMo admitting to having over 40 million 3G subs, and other markets also gaining a higher 3G penetration. As GSM is
|
more...
|
1/8/2008
|
$3,100.00
|
|
The World Dermatological Market Analysis & Forecasts 2007-2022
By: Visiongain
Most skin disorders are not fatal but most people are affected globally. The revenue of dermatological market in 2006 was $16bn, which is a 5.1% when compared with 2003. The common skin disorders include acne,
|
more...
|
11/26/2007
|
$3,100.00
|
|
Quad-Play and Service bundling strategy 2007-2012
By: Visiongain
Are Virgin Media dropping quadplay?
How effective is Tiscali’s quad-play strategy?
Is neuf cegetel’s revenue increase thanks to Quad-play?
These are just some of the questions this in-depth report will help you answer. Customers and
|
more...
|
11/23/2007
|
$3,100.00
|
|
The Anti-Migraine Market 2007-2022
By: Visiongain
Migraine is a serious neurological disorder characterised by recurrent headaches, varying in severity and frequency. Accounting for the loss of over 100 million working days in the US alone, the economic cost and social impact
|
more...
|
11/13/2007
|
$3,100.00
|
|
Title
|
Published
|
Price
|
(0 items)
